Is Gut Indexed in PubMed? Yes, and It Sits in the Core Clinical Set

Strong Gut papers often need to reach:

• gastroenterologists
• hepatologists
• translational digestive-disease researchers
• microbiome and mucosal-biology groups
• evidence-synthesis and guideline teams

Those readers usually search by disease, mechanism, treatment question, or biomarker rather than by browsing the journal issue. PubMed visibility matters because it helps the paper surface in those real GI and liver workflows.

This journal is another good example of why the fields matter separately:

• PubMed means the paper is discoverable in the standard biomedical search system.
• MEDLINE means the journal is actively inside the curated NLM journal index.
• Core clinical journals (AIM) means the journal also sits near the center of practical clinical reading.

For Gut, that helps explain why the journal has influence well beyond simple brand prestige.

This page answers the discoverability question. It does not answer whether the manuscript deserves a Gut audience.

Indexing tells you the paper will be visible. It does not tell you whether the study carries the broad digestive-disease importance the journal expects.

That is why the better next reads are:

• Is Gut a good journal?
• Gut submission guide
• Gut submission process
• Gut acceptance rate

Yes, Gut is indexed in PubMed and currently indexed for MEDLINE, and the core-clinical-journals signal makes the visibility story even stronger.

If your question is whether a published paper will be visible in the main GI and liver search workflow, the answer is yes. If your real question is whether the manuscript belongs in Gut, that is a separate fit decision. A free Manusights scan is the best next step if you want that call before submission.